BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15028804)

  • 1. A new era for transjugular intrahepatic portosystemic shunts?
    Saxon RR
    J Vasc Interv Radiol; 2004 Mar; 15(3):217-9. PubMed ID: 15028804
    [No Abstract]   [Full Text] [Related]  

  • 2. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft.
    Hausegger KA; Karnel F; Georgieva B; Tauss J; Portugaller H; Deutschmann H; Berghold A
    J Vasc Interv Radiol; 2004 Mar; 15(3):239-48. PubMed ID: 15028808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S
    World J Gastroenterol; 2014 Dec; 20(45):16996-7010. PubMed ID: 25493012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
    Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of refractory hepatic encephalopathy associated with insertion of a transjugular intrahepatic portosystemic shunt through new endovascular techniques: a case report].
    Martínez Moreno B; Bellot P; de España F; Palazón JM; Such J; Pérez-Mateo M
    Gastroenterol Hepatol; 2011; 34(7):468-73. PubMed ID: 21652116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension].
    Fang DC; Chen L
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):244-6. PubMed ID: 19403016
    [No Abstract]   [Full Text] [Related]  

  • 7. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.
    Bureau C; Garcia Pagan JC; Layrargues GP; Metivier S; Bellot P; Perreault P; Otal P; Abraldes JG; Peron JM; Rousseau H; Bosch J; Vinel JP
    Liver Int; 2007 Aug; 27(6):742-7. PubMed ID: 17617116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 'Gerstmann's Syndrome' of transjugular intrahepatic portosystemic shunt: should it be the left or should it be the right.
    Wong F
    Liver Int; 2009 Sep; 29(8):1129-31. PubMed ID: 19689612
    [No Abstract]   [Full Text] [Related]  

  • 9. [Portosystemic shunts versus endoscopic therapy for esophageal varices after the first bleeding: does the Cochrane analysis give a complete answer?].
    Grønbaek H; Thomsen KL; Ott P; Vilstrup H
    Ugeskr Laeger; 2007 Aug; 169(34):2761-3. PubMed ID: 17878011
    [No Abstract]   [Full Text] [Related]  

  • 10. Using transjugular intrahepatic portosystemic shunts for complications of cirrhosis.
    Bhogal HK; Sanyal AJ
    Clin Gastroenterol Hepatol; 2011 Nov; 9(11):936-46; quiz e123. PubMed ID: 21699820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.
    Luo X; Zhao M; Wang X; Jiang M; Yu J; Li X; Yang L
    PLoS One; 2019; 14(2):e0212658. PubMed ID: 30811467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of complications of portal hypertension in patients with liver cirrhosis].
    Grønbaek H; Astrup LB; Nielsen DT; Vilstrup H
    Ugeskr Laeger; 2003 Jan; 165(5):439-42. PubMed ID: 12599838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Efficacy of Transjugular Intrahepatic Portosystemic Shunt Created with Expanded Polytetrafluoroethylene-Covered Stent-Grafts: 8-mm Versus 10-mm.
    Luo X; Wang X; Zhu Y; Xi X; Zhao Y; Yang J; Li X; Yang L
    Cardiovasc Intervent Radiol; 2019 May; 42(5):737-743. PubMed ID: 30643936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy.
    Pereira K; Carrion AF; Martin P; Vaheesan K; Salsamendi J; Doshi M; Yrizarry JM
    Liver Int; 2015 Dec; 35(12):2487-94. PubMed ID: 26332169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding ectopic varices in cirrhosis: the role of transjugular intrahepatic portosystemic stent shunts.
    Kochar N; Tripathi D; McAvoy NC; Ireland H; Redhead DN; Hayes PC
    Aliment Pharmacol Ther; 2008 Aug; 28(3):294-303. PubMed ID: 19086235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemolytic anemia secondary to the placement of a portosystemic stented shunt].
    Carrillo-Esper R; Carrillo-Cortes U; Carrillo-Córdova JR; Carrillo-Córdova LD; Carrillo-Córdova CA; Carrillo-Córdova DM
    Cir Cir; 2013; 81(2):143-7. PubMed ID: 23522316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transjugular intrahepatic portosystemic shunt for the prevention of recurrent esophageal variceal bleeding in patients with cavernous transformation of portal vein.
    Li ZP; Wang SS; Wang GC; Huang GJ; Cao JQ; Zhang CQ
    Hepatobiliary Pancreat Dis Int; 2018 Dec; 17(6):517-523. PubMed ID: 30262421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary Obstruction following Transjugular Intrahepatic Portosystemic Shunt Creation in Patients with Variceal Bleeding.
    Meng J; Yang S; Ding W; He C; Wu X
    J Vasc Interv Radiol; 2016 Apr; 27(4):558-61. PubMed ID: 27013003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis.
    Yang Z; Han G; Wu Q; Ye X; Jin Z; Yin Z; Qi X; Bai M; Wu K; Fan D
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1718-25. PubMed ID: 21039832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved clinical outcome with transjugular intrahepatic portosystemic stent-shunt utilizing polytetrafluoroethylene-covered stents.
    Tripathi D; Ferguson J; Barkell H; Macbeth K; Ireland H; Redhead DN; Hayes PC
    Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):225-32. PubMed ID: 16462534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.